pI: 7.2047 |
Length (AA): 460 |
MW (Da): 54309 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 1
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 3 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
34 | 306 | 1o7d (A) | 51 | 340 | 43.00 | 0 | 1 | 1.01578 | 0.1 |
34 | 456 | 6b9o (A) | 2 | 441 | 37.00 | 0 | 1 | 1.31387 | -0.22 |
394 | 438 | 1o7d (C) | 436 | 480 | 49.00 | 0.0000029 | 0.38 | 0.649326 | -0.33 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Ortholog group members (OG5_129192)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT5G13980 | Glycosyl hydrolase family 38 protein |
Arabidopsis thaliana | AT3G26720 | glycosyl hydrolase family 38 protein |
Arabidopsis thaliana | AT5G66150 | Glycosyl hydrolase family protein |
Caenorhabditis elegans | CELE_F55D10.1 | Protein AMAN-1 |
Dictyostelium discoideum | DDB_G0292206 | hypothetical protein |
Drosophila melanogaster | Dmel_CG5322 | CG5322 gene product from transcript CG5322-RB |
Drosophila melanogaster | Dmel_CG9466 | CG9466 gene product from transcript CG9466-RB |
Drosophila melanogaster | Dmel_CG9465 | CG9465 gene product from transcript CG9465-RB |
Drosophila melanogaster | Dmel_CG6206 | Lysosomal alpha-mannosidase |
Drosophila melanogaster | Dmel_CG9463 | CG9463 gene product from transcript CG9463-RB |
Drosophila melanogaster | Dmel_CG9468 | CG9468 gene product from transcript CG9468-RA |
Echinococcus granulosus | EgrG_000704400 | lysosomal alpha mannosidase |
Echinococcus multilocularis | EmuJ_000704400 | lysosomal alpha mannosidase |
Homo sapiens | ENSG00000104774 | mannosidase, alpha, class 2B, member 1 |
Loa Loa (eye worm) | LOAG_00101 | hypothetical protein |
Mus musculus | ENSMUSG00000005142 | mannosidase 2, alpha B1 |
Oryza sativa | 4350617 | Os11g0525600 |
Oryza sativa | 4348080 | Os10g0140200 |
Schistosoma japonicum | Sjp_0032110 | Lysosomal alpha-mannosidase precursor, putative |
Schistosoma japonicum | Sjp_0032090 | ko:K01191 alpha-mannosidase [EC3.2.1.24], putative |
Schistosoma mansoni | Smp_131580 | lysosomal alpha-mannosidase (mannosidase alpha class 2b member 1) |
Schmidtea mediterranea | mk4.002033.03 | |
Schmidtea mediterranea | mk4.020205.00 | |
Trypanosoma brucei gambiense | Tbg972.10.3200 | lysosomal alpha-mannosidase precursor, putative |
Trypanosoma brucei | Tb11.v5.0498 | lysosomal alpha-mannosidase precursor, putative |
Trypanosoma brucei | Tb927.10.2570 | lysosomal alpha-mannosidase precursor, putative |
Trypanosoma cruzi | TcCLB.506195.120 | lysosomal alpha-mannosidase precursor, putative |
Trypanosoma cruzi | TcCLB.506407.10 | lysosomal alpha-mannosidase precursor, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.10.2570 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.10.2570 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.10.2570 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.10.2570 | Trypanosoma brucei | significant gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Canavalia ensiformis | Alpha-mannosidase | Compounds | References |
Homo sapiens | mannosidase, alpha, class 2B, member 1 | Compounds | References |